Astrocytes in the Neuropathology of Bipolar Disorder: Review of Current Evidence

(1) Background: Approximately one-third of patients with bipolar disorder (BD) do not experience sustained remission with current treatments. Presently, astrocytes, i.e., glial cells that act as key regulators of neuroinflammation, have been a target for therapeutic development. Research regarding t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Nasia, Jones, Brett D. M., Husain, Muhammad Ishrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688542/
https://www.ncbi.nlm.nih.gov/pubmed/36358439
http://dx.doi.org/10.3390/brainsci12111513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688542/
https://www.ncbi.nlm.nih.gov/pubmed/36358439
http://dx.doi.org/10.3390/brainsci12111513

Ejemplares similares